Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Expert opinion on therapeutic targets

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/14728222.6.4.507PMID 12223065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ratiometric single-molecule studies of freely diffusing biomolecules.

  2001cited by this paper
• GcpE Is Involved in the 2-C-Methyl-d-Erythritol 4-Phosphate Pathway of Isoprenoid Biosynthesis in Escherichia coli

  2001cited by this paper
• Single-molecule fluorescence resonance energy transfer.

  2001cited by this paper
• Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance.

  2001cited by this paper
• The impact of microbial genomics on antimicrobial drug development.

  2001cited by this paper
• Increasing prevalence of antimicrobial resistance in intensive care units

  2001cited by this paper
• High-throughput screening strategies for cardiac ion channels.

  2001cited by this paper
• The Potential for CYP2D6 Inhibition Screening Using a Novel Scintillation Proximity Assay-Based Approach

  2001cited by this paper
• Inhibitors of aminoacyl-tRNA synthetases as novel anti-infectives

  2000cited by this paper
• Molecular mechanisms that confer antibacterial drug resistance

  2000cited by this paper
• Recent trends in protein biochip technology.

  2000cited by this paper
• Identification of differential gene expression by high throughput analysis.

  2000cited by this paper
• Isolation of peptide aptamers that inhibit intracellular processes.

  2000cited by this paper
• Time-resolved fluorescence spectroscopy

  2000cited by this paper
• DNA microarray technology and antimicrobial drug discovery.

  2000cited by this paper
• Drug target validation: lethal infection blocked by inducible peptide.

  2000cited by this paper
• Detection of small-molecule enzyme inhibitors with peptides isolated from phage-displayed combinatorial peptide libraries.

  2000cited by this paper
• Transposon-based approaches to identify essential bacterial genes.

  2000cited by this paper
• Ribosome display: an in vitro method for selection and evolution of antibodies from libraries.

  1999cited by this paper
• Antimicrobial resistance in intensive care units.

  1999cited by this paper
• Global transposon mutagenesis and a minimal Mycoplasma genome.

  1999cited by this paper
• New approaches to rational drug design.

  1999cited by this paper
• Fluorescence polarization: an analytical tool for immunoassay and drug discovery.

  1999cited by this paper
• Methods of screening combinatorial libraries using immobilized or restrained receptors.

  1999cited by this paper
• Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes

  1999cited by this paper
• Identification of novel staphylococcal virulence genes by in vivo expression technology

  1998influential reference
• Systematic identification of essential genes by in vitro mariner mutagenesis.

  1998cited by this paper
• Metabolic databases.

  1998cited by this paper
• Displaying libraries of conformationally constrained peptides on the surface of Escherichia coli as flagellin fusions.

  1998cited by this paper
• A vector for systematic gene inactivation in Bacillus subtilis.

  1998cited by this paper
• A genome-based approach for the identification of essential bacterial genes

  1998cited by this paper
• The challenge of antibiotic resistance.

  1998cited by this paper
• Use of Representational Difference Analysis To Identify Genomic Differences between Pathogenic Strains of Vibrio cholerae

  1998cited by this paper
• Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression.

  1998cited by this paper
• Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements.

  1997cited by this paper
• Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization

  1997cited by this paper
• Microbial pathogenesis: genomics and beyond.

  1997cited by this paper
• The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

  1997cited by this paper
• Emergent antibiotic resistance: health risks and economic impact.

  1997cited by this paper
• vaccine in The Netherlands . persons vaccinated with inactivated poliovirus Poliovirus-specific immunoglobulin A in

  1997cited by this paper
• The complete genome sequence of Escherichia coli K-12.

  1997cited by this paper
• Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature‐tagged mutagenesis

  1997cited by this paper
• The Escherichia coli genome sequence: the end of an era or the start of the FUN?

  1997cited by this paper
• Pathogenicity islands: bacterial evolution in quantum leaps.

  1996cited by this paper
• Pathogenicity Islands: Minireview Bacterial Evolution in Quantum Leaps

  1996cited by this paper
• Antimicrobial-drug resistance.

  1996cited by this paper
• Imaging of single molecule diffusion.

  1996cited by this paper
• Sequencing and analysis of bacterial genomes.

  1996cited by this paper
• Trends in infectious diseases mortality in the United States.

  1996cited by this paper
• The minimal cell genome: "on being the right size".

  1996cited by this paper
• New targets and strategies for the development of antibacterial agents.

  1996cited by this paper
• A minimal gene set for cellular life derived by comparison of complete bacterial genomes.

  1996cited by this paper
• Generation and use of nonsupport-bound peptide and peptidomimetic combinatorial libraries.

  1996cited by this paper
• Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid‐inducible promoters by differential fluorescence induction

  1996cited by this paper
• Synthetic combinatorial libraries: novel discovery strategy for identification of antimicrobial agents

  1996cited by this paper
• Time-resolved fluorescence spectroscopy.

  1996cited by this paper
• Ultrasensitive bioanalytical assays using time-resolved fluorescence detection.

  1995cited by this paper
• Mechanism-based screens in the discovery of chemotherapeutic antibacterials.

  1994cited by this paper
• Libraries of peptides and proteins displayed on filamentous phage.

  1993cited by this paper
• The Crisis in Antibiotic Resistance

  1992cited by this paper
• Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of Escherichia coli

  1992cited by this paper
• Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome

  1991cited by this paper
• Peptides on phage: a vast library of peptides for identifying ligands.

  1990cited by this paper
• Antimicrobial resistance in the intensive care unit.

  1990cited by this paper
• Ciprofloxacin in combination with other antimicrobials.

  1989cited by this paper
• Common themes in microbial pathogenicity

  1989cited by this paper
• Genetic analysis of temperature-sensitive lethal mutants of Salmonella typhimurium.

  1989cited by this paper
• Homology of the TetM with translational elongation factors: implications for potential modes of tetM-conferred tetracycline resistance.

  1988cited by this paper
• Antisense RNA: its functions and applications in gene regulation--a review.

  1988cited by this paper
• Antibiotic synergism and antimicrobial combinations in clinical infections.

  1982cited by this paper

• Molluscicide Screening and Identification of Novel Targets Against Pomacea canaliculata.

  2024cites this paper
• Discovery and Validation of a Novel Target of Molluscicides against Oncomelania hupensis, the Intermediate Host of Schistosoma japonicum.

  2021cites this paper
• Antimicrobial, analgesic, DPPH scavenging activities and molecular docking study of some 1,3,5-triaryl-2-pyrazolines

  2012cites this paper
• Actividad ATP hidrolasa asociada a ribosomas humanos como nuevo indicador para evaluar fármacos in vitro.

  2007cites this paper